About Asahi Kasei
Asahi Kasei is a publicly listed company based in Tokyo (Japan) founded in 1931. CDMO focused on manufacturing of liquid, solid injectable drug formulations. It operates in the Chemicals & Materials and Healthcare sectors. The company has 50,350 employees. Asahi Kasei has completed 1 acquisition, including AiCuris. Its chief executive, as recorded, is Hideki Kobori. Its website asahi-kasei.com draws about 161 thousand monthly visits. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and Formulation. Its legal entity is Asahi Kasei Pharma Denmark A/S.
Company details
Asahi Kasei was established in 1931 in Tokyo, Japan, and operates as a contract development and manufacturing organization in the pharmaceutical sector. Focus is placed on producing liquid, solid, and injectable drug formulations for clients. Services encompass development and manufacturing processes tailored to pharmaceutical needs. Leadership is provided by President and CEO Hideki Kobori, with headquarters maintained in Tokyo.
- Headquarters Tokyo, Japan
- Employees 50,350
- Stage Public
- SectorsChemicals & MaterialsHealthcare
- Website category Heavy Industry and Engineering · Chemical Industry
- Website asahi-kasei.com
- Social LinkedIn YouTube
- Legal Name Asahi Kasei Corporation
- Annual Revenue$19.25 B (USD)1.22as on Mar 31, 2026
- Net Profit$995.57 M (USD)17.63as on Mar 31, 2026
- EBITDA$2.68 B (USD)7.42as on Mar 31, 2026
- Investors
- Employee Count50,350
- Investments & Acquisitions
Apps and channels of Asahi Kasei
its YouTube channel Asahi Kasei Official has 3.73K subscribers and 30 videos.
Videos from Asahi Kasei
The most watched videos on Asahi Kasei's YouTube channel, Asahi Kasei Official (3.73K subscribers). Click a video to play it here.
More on Asahi Kasei Official.
Funding Insights of Asahi Kasei
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of Asahi Kasei with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2015 | Grant | – | – |
1 investors in total: 1 institutional.
Investors in Asahi Kasei
Asahi Kasei has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for Asahi Kasei
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Asahi Kasei
45 people are tracked at Asahi Kasei (9 in leadership, 10 in board & advisors, 26 in team); the tracked headcount is 50,350.
| Name | Role | Group |
|---|---|---|
Hideki Kobori | President & CEO | Leadership |
Yukifumi Kuwaba | President, Performance Products SBU | Leadership |
Yoshihito Itani | Senior General Manager, Mizushima Works | Leadership |
Minoru Suetsugu | Senior General Manager, Nobeoka Office | Leadership |
Hunsul Chu | Director, New Business Development At Asahi Kasei E-materials Korea | Leadership |
Akira Nishizawa | President, Asahi Kasei Advance Corporation | Leadership |
Satoshi Nishikawa | Senior General Manager, Human Resources | Leadership |
Stepan Kazakov | AK Battery Separator NA Business Unit: VP Of IT | Leadership |
Hideyuki Yamagishi | President, Specialty Solutions SBU | Leadership |
Chieko Matsuda | Director | Board & advisors |
Takuya Magara | Supervisory Board Member | Board & advisors |
Yoshikazu Ochiai | Outside Audit & Supervisory Board Member | Board & advisors |
Yutaka Shibata | Audit & Supervisory Board Member | Board & advisors |
Tsuyoshi Okamoto | Outside Director | Board & advisors |
Akemi Mochizuki | Board Member | Board & advisors |
Yuko Maeda | Director | Board & advisors |
Richard A. Packer | Executive Officer, Health Care Business Sector | Board & advisors |
Koshiro Kudo | Director | Board & advisors |
Haruyuki Urata | Outside Audit & Supervisory Board Member | Board & advisors |
Elijah A. White | Executive Officer | Team |
25 more people are available in the full profile.
Complete people profiles for Asahi Kasei
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Asahi Kasei
Asahi Kasei is a publicly listed company on the TSE with ticker symbol 3407 in Japan, operating in the Process industries sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date07 Jan 2000
- Listed onTSE: 3407
- Listed entityAsahi Kasei Corporation
- Exchange sectorProcess industries
- ISINJP3111200006
- Share price1,596.00 JPY (-0.13% on the day) · 2026-10-14
- Market capitalisation2,172,124,024,902.00 JPY
- Price to earnings11.2
- EPS (diluted, trailing year)142.18 JPY
- Dividend yield2.75%
- Volume (last session)4,447,500
Financials of Asahi Kasei
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 3,070.00B JPY | 158.79B JPY | 427.54B JPY |
| 2024 | 3,040.00B JPY | 135.00B JPY | 398.03B JPY |
| 2023 | 2,780.00B JPY | 43.81B JPY | 322.94B JPY |
| 2022 | 2,730.00B JPY | -91.95B JPY | 305.00B JPY |
| 2021 | 2,460.00B JPY | 161.88B JPY | 350.77B JPY |
Detailed financial statements for Asahi Kasei
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Asahi Kasei
Asahi Kasei has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include AiCuris.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Antiviral and antibacterial therapeutics for infectious diseases are developed. | aicuris.com | Wuppertal, Germany | 2006 | Feb 2026 | $919.92M |
Complete acquisition details for Asahi Kasei
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Asahi Kasei
4 dated milestones of Asahi Kasei across 95 years, from founding to its latest funding, stage changes and deals.
- Founded Asahi Kasei is founded.
- IPO Lists on the stock exchange (IPO).
- Funding First funding round.
- Acquisition Acquires AiCuris.
Web traffic of Asahi Kasei
The website of Asahi Kasei (asahi-kasei.com) receives about 161K visits a month and ranks #284,376 among all websites worldwide, #3,118 in Chemical Industry.
- Monthly visits161K
▲ 26.3% vs previous month
- Unique visitors68.1K
per month
- Global rank#284,376
among all websites
- Category rank#3,118
Heavy Industry and Engineering · Chemical Industry
- Bounce rate42%
- Pages per visit2.7
- Average visit1 min 35 sec
- DevicesDesktop 59% · Mobile 41%
Websites whose visitors overlap most with Asahi Kasei. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
asahi-kasei-jobs.com | asahi-kasei-jobs.com | 100% | #1,453,769 | – | |
| mcgc.com | 84% | 157.7K | #268,742 | View details | |
| sekisui.co.jp | 77% | 465.7K | #62,809 | View details | |
| sumitomo-chem.co.jp | 72% | 95.9K | #390,249 | View details | |
toray.co.jp | toray.co.jp | 68% | #442,752 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for Asahi Kasei
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Asahi Kasei
Complete news archive for Asahi Kasei
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Asahi Kasei
Asahi Kasei was founded in 1931 and raised its 1st funding round 84 years after it was founded.
Asahi Kasei is headquartered in Tokyo, Japan. It is registered at Tokyo, Tokyo, Japan.
Hideki Kobori is the CEO of Asahi Kasei, as recorded in our data.
Asahi Kasei has 50,350 employees.
Annual revenue of Asahi Kasei is $19.25B as on Mar 31, 2026.
Asahi Kasei was established in 1931 in Tokyo, Japan, and operates as a contract development and manufacturing organization in the pharmaceutical sector. Focus is placed on producing liquid, solid, and injectable drug formulations for clients. Services encompass development and manufacturing processes tailored to pharmaceutical needs. Leadership is provided by President and CEO Hideki Kobori, with headquarters maintained in Tokyo.
Yes, Asahi Kasei is publicly traded on TSE under the ticker symbol 3407.
Asahi Kasei has made 1 acquisition, including AiCuris.
Asahi Kasei has 1 investor. Key investors include European Union.
Asahi Kasei operates through Asahi Kasei Pharma Denmark A/S.
The website of Asahi Kasei receives about 161 thousand visits a month and ranks #284,376 among all websites worldwide.